Perrigo (NY: PRGO )
32.39 -0.11 (-0.34%) Official Closing Price Updated: 7:00 PM EDT, May 26, 2023 Add to My Watchlist
Headline News about Perrigo
FDA Raises Concerns Regarding Perrigo's OTC Birth Control Pill, Casts Doubts Over Real-World Use
May 08, 2023
The FDA's Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee (ORUDAC) will be meeting this week to review Perrigo Company...
Earnings Outlook For Perrigo Co
February 24, 2023
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
November 09, 2022
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
November 08, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...
Perrigo Shares Fall As Investors React To Lowered FY22 Profit Guidance
November 08, 2022
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...
FDA Schedules AdComm Review For First Over The Counter Birth Control Pill
September 13, 2022
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022
September 06, 2022
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
July 11, 2022
This $5B Pharmaceutical Could Benefit From Over-The-Counter Contraceptives And Plan B Alternatives
June 27, 2022
The ruling by the U.S. Supreme Court to overturn Roe v. Wade and leave the decision of abortion to the states has been a big topic over the last few days. An analyst singles out a pharmaceutical...
Cannabis Movers & Shakers: MedMen's New CEO, TerrAscend, FoliuMed, Charlotte's Web & Proof Announce Appointments
April 29, 2022
MedMen Names New CEO Cannabis retailer MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) has appointed a new CEO, Edward Record, who has been serving on the company's board since 2021.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following